Best Cannabis Stocks Under $5
Updated March 2026Cannabis stocks trading below $5 per share, ranked by market capitalization. Find the most promising low-priced marijuana stocks.
Cannabis stocks under $5 occupy a unique sweet spot for investors who want exposure to the marijuana sector without a large per-share price commitment. Many of these companies are established operators with real revenue and tangible assets, yet their share prices remain suppressed due to federal illegality in the United States, limited institutional ownership, and the lingering effects of sector-wide sell-offs that began in 2021.
Investing in sub-$5 cannabis stocks can offer outsized upside if federal reform catalysts materialize — such as rescheduling, SAFE Banking passage, or eventual legalization. A single positive legislative headline has historically sent the entire sector up 15-30% in a single session. At the same time, these lower-priced names tend to be more volatile on the downside, so position sizing and due diligence are critical.
The table below ranks every cannabis stock trading below $5.00 by market capitalization, which serves as a rough proxy for business scale and institutional confidence. Larger-cap names within this price bracket tend to have more liquid order books and broader analyst coverage.
Best Cannabis Stocks Under $5 — Full Rankings
30 stocks · Ranked by market cap
| # | Ticker | Name | Price | Change | Market Cap | Revenue | Margin | P/S | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CURLF | Curaleaf Holdings | $2.36 | +2.83% | $1.80B | $0 | — | — | $1.80B |
| 2 | CRON | Cronos Group | $2.50 | +0.81% | $947.6M | $146.6M | 36.4% | 6.46x | $947.6M |
| 3 | MSOS | AdvisorShares Pure US Cannabis ETF | $3.82 | +1.33% | $764.3M | $0 | — | — | $764.3M |
| 4 | VRNOF | Verano Holdings | $1.26 | -8.70% | $457.6M | $0 | — | — | $457.6M |
| 5 | SNDL | SNDL Inc | $1.51 | -5.03% | $388.8M | $0 | — | — | $388.8M |
| 6 | CGC | Canopy Growth | $1.02 | -2.86% | $385.4M | $278.4M | 28.8% | 1.38x | $385.4M |
| 7 | CRLBF | Cresco Labs | $0.97 | -0.27% | $346.1M | $0 | — | — | $346.1M |
| 8 | VFF | Village Farms International | $2.87 | -6.51% | $331.5M | $253.3M | 38.7% | 1.31x | $331.5M |
| 9 | PLNHF | Planet 13 Holdings | $0.91 | +5.21% | $295.8M | $0 | — | — | $295.8M |
| 10 | TSNDF | TerrAscend Corp | $0.68 | +0.37% | $261.4M | $0 | — | — | $261.4M |
| 11 | CCHWF | Columbia Care | $1.14 | -4.20% | $232.6M | $0 | — | — | $232.6M |
| 12 | HITI | High Tide Inc | $2.46 | +2.50% | $216.1M | $0 | — | — | $216.1M |
| 13 | ACB | Aurora Cannabis | $3.43 | -3.65% | $194.5M | $0 | — | — | $194.5M |
| 14 | OGI | Organigram Holdings | $1.41 | -2.76% | $190.6M | $0 | — | — | $190.6M |
| 15 | GDNSF | Vireo Growth (Goodness Growth) | $0.44 | -1.12% | $182.2M | $0 | — | — | $182.2M |
| 16 | CBWTF | Auxly Cannabis Group | $0.09 | +1.07% | $111.6M | $0 | — | — | $111.6M |
| 17 | CWBHF | Charlotte's Web Holdings | $0.62 | -0.22% | $99.3M | $0 | — | — | $99.3M |
| 18 | JUSHF | Jushi Holdings | $0.49 | -0.26% | $96.4M | $0 | — | — | $96.4M |
| 19 | LOVFF | Cannara Biotech | $1.30 | -5.09% | $81.9M | $0 | — | — | $81.9M |
| 20 | MAPS | WM Technology (Weedmaps) | $0.68 | -7.27% | $73.0M | $174.7M | 94.9% | 0.42x | $73.0M |
| 21 | HEXO | HEXO Corp | $0.71 | +5.62% | $68.9M | $0 | — | — | $68.9M |
| 22 | FORA | Forian Inc | $2.05 | -0.97% | $63.7M | $28.1M | 51.6% | 2.27x | $63.7M |
| 23 | GRWG | GrowGeneration | $1.06 | -2.75% | $63.4M | $161.4M | 27.2% | 0.39x | $63.4M |
| 24 | AFCG | AFC Gamma (Advanced Flower Capital) | $2.63 | +0.38% | $61.9M | $24.6M | — | 2.52x | $61.9M |
| 25 | NVACF | Nova Cannabis | $1.26 | -0.47% | $50.6M | $0 | — | — | $50.6M |
| 26 | AAWH | Ascend Wellness Holdings | $0.49 | -0.89% | $47.0M | $0 | — | — | $47.0M |
| 27 | GRAMF | TPCO Holding (The Parent Company) | $0.16 | -12.99% | $45.7M | $0 | — | — | $45.7M |
| 28 | DBCCF | Decibel Cannabis Co | $0.09 | +7.20% | $36.1M | $0 | — | — | $36.1M |
| 29 | VEXTF | Vext Science | $0.19 | 0.00% | $34.2M | $0 | — | — | $34.2M |
| 30 | ZYNE | Zynerba Pharmaceuticals | $1.30 | +3.17% | $33.8M | $0 | — | — | $33.8M |
Top 3 Spotlight
Curaleaf Holdings
Curaleaf Holdings ranks #1 in the best cannabis stocks under $5 category with a share price of $2.36 and a market capitalization of $1.80B. The company operates in the MSO sector and is listed on the OTC. With trailing twelve-month revenue of $0 and a gross margin of N/A, CURLF represents the top-ranked stock in this category based on market cap.
Cronos Group
Cronos Group ranks #2 in the best cannabis stocks under $5 category with a share price of $2.50 and a market capitalization of $947.6M. The company operates in the LP sector and is listed on the NASDAQ. With trailing twelve-month revenue of $146.6M and a gross margin of 36.4%, CRON represents the second-ranked stock in this category based on market cap.
AdvisorShares Pure US Cannabis ETF
AdvisorShares Pure US Cannabis ETF ranks #3 in the best cannabis stocks under $5 category with a share price of $3.82 and a market capitalization of $764.3M. The company operates in the ETF sector and is listed on the NYSE. With trailing twelve-month revenue of $0 and a gross margin of N/A, MSOS represents the third-ranked stock in this category based on market cap.
Methodology
Stocks are filtered to include only cannabis companies with a share price below $5.00 and ranked in descending order by market capitalization. Data is sourced from company filings, exchange feeds, and financial data providers. Rankings update automatically as new data becomes available. All financial figures are based on trailing twelve-month (TTM) data unless otherwise noted. The current ranking includes 30 qualifying stocks out of 100 total cannabis companies tracked by Cannabismarketcap.
Key Observations
The top-ranked stock in the best cannabis stocks under $5 category is CURLF (Curaleaf Holdings) with a market cap of $1.80B. The stock trades at $2.36 per share with a market capitalization of $1.80B. In second place is CRON ($947.6M), followed by MSOS ($764.3M) in third.
Across all 30 qualifying stocks, the average share price is $1.33 and the average market capitalization is $265.3M. The combined trailing twelve-month revenue of all companies in this category is $1.07B. The average gross margin among companies with positive margins is 46.3%. The average price-to-sales ratio is 2.11x.
The most represented sector in this category is LP with 12 out of 30 companies (40%). Among the ranked stocks, 11 are trading higher today while 18 are trading lower. Investors should use these observations as a starting point for further research rather than as the basis for trading decisions.
Investment Considerations
When evaluating stocks in the best cannabis stocks under $5 category, consider looking beyond the primary ranking metric to build a holistic view of each company. A stock that ranks well by market cap may have weaknesses in other areas — such as high debt, poor margins, or slowing growth — that the ranking alone does not capture. Cross-reference this list with other Cannabismarketcap category pages and the screener tool to identify stocks that score well across multiple dimensions.
Position sizing is particularly important in cannabis. The sector is inherently volatile, and even the strongest companies can experience 30-50% drawdowns during sector-wide sell-offs triggered by legislative disappointments or broader market risk-off events. Most financial advisors suggest limiting total cannabis exposure to 5-15% of your portfolio, and individual positions to 1-3% depending on your risk tolerance and conviction level.
Dollar-cost averaging (DCA) is a widely recommended approach for building cannabis stock positions over time. Rather than investing your entire allocation at a single price point, spreading purchases across weeks or months can reduce the impact of short-term volatility and lower your average cost basis if prices decline after your initial purchase. This strategy is particularly relevant for the stocks in this category given the sector's history of sharp and sometimes prolonged drawdowns.
Risk Factors
Risk Warning
Stocks under $5 carry heightened risks including potential delisting from major exchanges if prices remain below minimum thresholds, wider bid-ask spreads that increase trading costs, and limited institutional coverage. Many sub-$5 cannabis companies are burning cash and may need to raise capital through dilutive equity offerings. Reverse stock splits are common in this price range and often signal ongoing financial stress. Always verify a company's cash runway and debt maturity schedule before investing.
Compare These Stocks
Head-to-head comparisons between top-ranked stocks in this category.
Frequently Asked Questions
Are cannabis stocks under $5 considered penny stocks?
Not necessarily. The SEC defines penny stocks as securities trading below $5 that are not listed on a national exchange. Many cannabis stocks under $5 trade on major exchanges like NASDAQ, NYSE, or the Canadian Securities Exchange and are therefore not classified as penny stocks under the SEC definition. However, stocks trading on OTC Markets below $5 generally do qualify as penny stocks and carry additional regulatory requirements for brokers executing trades.
Why are so many cannabis stocks priced below $5?
Several structural factors keep cannabis stock prices low. Federal prohibition in the United States prevents major institutional investors, index funds, and many mutual funds from holding cannabis equities. This limits the buyer pool and suppresses valuations. Additionally, the 280E tax provision denies standard business deductions to plant-touching companies, squeezing margins and free cash flow. The sector also experienced a speculative bubble in 2021 followed by a prolonged drawdown, and many companies have diluted shares through at-the-market (ATM) offerings to fund operations.
What catalysts could move cannabis stocks under $5 higher?
The most significant potential catalysts include federal rescheduling of cannabis from Schedule I to Schedule III (which would eliminate 280E), passage of the SAFE Banking Act (which would open traditional banking and capital markets), and state-level legalization in large markets like Pennsylvania, Ohio, or Florida. Company-specific catalysts include achieving GAAP profitability, positive free cash flow, and successful license wins in new state markets.
How should I evaluate a cannabis stock trading under $5?
Focus on fundamentals over share price. Key metrics include trailing twelve-month revenue and the growth trajectory, gross margin (ideally above 40%), cash on hand relative to quarterly cash burn, total debt and upcoming maturity dates, and the price-to-sales ratio compared to sector peers. Also check the dilution rate — companies aggressively issuing new shares will erode your ownership stake over time. A stock with a low price but strong revenue growth and manageable debt is far more attractive than one that is cheap simply because the business is deteriorating.
More on Cannabismarketcap
Disclaimer: The information on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Cannabis stocks are highly speculative and carry significant risk of loss, including the potential loss of your entire investment. Past performance is not indicative of future results. The rankings and data presented are based on publicly available financial information and may contain errors or omissions. Always do your own research and consult with a qualified financial advisor before making investment decisions. Cannabismarketcap is not a registered investment advisor, broker-dealer, or financial planner.